Financing NewsiCo Therapeutics completes $475,000 financing
2009-07-16 16:32 ET - News Release
Dr. John Clement reports
ICO THERAPEUTICS CLOSES NON-BROKERED PRIVATE PLACEMENT
ICo Therapeutics Inc. has completed a non-brokered private placement in the amount of $475,000 through the issuance of 1,187,500 common shares in the capital of the company at a subscription price of 40 cents per share. The company intends to use the net proceeds for working capital and general corporate purposes.
A finder's fee of 7 per cent will be payable to certain arm's-length third parties with respect to a portion of the private placement. All securities issued in the private placement are subject to a four-month hold period. The private placement is subject to regulatory approval, including the approval of the TSX Venture Exchange.
We seek Safe Harbor.